Last updated on April 16, 2014 at 4:54 EDT

Segasist launches Crowd-Funding Round for Cloud-Based Quality Assurance in Cancer Treatment

August 21, 2012

TORONTO, Aug. 21, 2012 /PRNewswire/ – Segasist Technologies, a Canadian
software company developing next-generation image contouring platforms
for biomedical applications, has launched a crowd funding campaign to
bring its software Reconcillio on cloud.

Reconcillio is the first technology to provide quality assurance in
treatment planning for radiation therapy. The software offers automated
consensus contouring of tumor images, which increases the safety,
accuracy and efficiency of radiation treatments. These markings, called
contours, are crucial for efficient treatment. The more accurate the
contours, the higher the success rate of killing cancer cells in a
shorter time. Inaccurate contouring can lead to partial tumor radiation
and damage to the surrounding healthy tissues.

Currently, there is no quality assurance for contouring. Cancer patients
have to rely on the knowledge and contouring skills of their doctor.
Unfortunately, it is well documented that clinicians, given the same
image, generally produce different contours. Depending on the tumor
type, size and location, studies have shown that clinicians’ contours
deviate considerably from each other ranging from 5% up to a
frightening 60% difference. This long-standing problem is called
“inter-observer variability” and results in suboptimal patient care and
a more costly treatment.

“So, what is the solution?” asks Hamid Tizhoosh, the CEO of Segasist
Technologies, “Ideally, we would have several doctors contour the tumor
images of one patient. From this, a ‘consensus contour’ that reflects
the collective knowledge of all the doctors is created to serve as a
benchmark for accurate measurements. This approach can drastically
reduce the variability and assure greater accuracy in treatment.”

Reconcilio was designed because no healthcare system can afford such a
multi-doctor approach.

“Taking this a step further” adds Tizhoosh, “our intention is to put
this technology on the ‘cloud’ in order to extend the software to a
large number of doctors and to cover many cancer cases. Software as a
Service (SaaS) will enable any doctor to request ‘consensus contours’
at any time.”

The crowd-funding project is accessible to potential supporters on
“MedStartr.com”: http://www.medstartr.com/projects/39-cloud-based-quality-assurance-for-cancer-treatment

Supporters receive different rewards, among others user/site licenses of
Segasist contouring software that they can use themselves or donate to
any hospital.

For more information contact: Dr. Hamid R. Tizhoosh, (647) 835-4077 or
visit www.segasist.com

SOURCE Segasist Technologies

Source: PR Newswire